APA (7th ed.) Citation

Chhabi Lal Chaudhary, Dongchul Lim, Prakash Chaudhary, Diwakar Guragain, Bhuwan Prasad Awasthi, Hee Dong Park, . . . Byeong-Seon Jeong. (2022). 6-Amino-2,4,5-trimethylpyridin-3-ol and 2-amino-4,6-dimethylpyrimidin-5-ol derivatives as selective fibroblast growth factor receptor 4 inhibitors: Design, synthesis, molecular docking, and anti-hepatocellular carcinoma efficacy evaluation. Taylor & Francis Group.

Chicago Style (17th ed.) Citation

Chhabi Lal Chaudhary, Dongchul Lim, Prakash Chaudhary, Diwakar Guragain, Bhuwan Prasad Awasthi, Hee Dong Park, Jung-Ae Kim, and Byeong-Seon Jeong. 6-Amino-2,4,5-trimethylpyridin-3-ol and 2-amino-4,6-dimethylpyrimidin-5-ol Derivatives as Selective Fibroblast Growth Factor Receptor 4 Inhibitors: Design, Synthesis, Molecular Docking, and Anti-hepatocellular Carcinoma Efficacy Evaluation. Taylor & Francis Group, 2022.

MLA (9th ed.) Citation

Chhabi Lal Chaudhary, et al. 6-Amino-2,4,5-trimethylpyridin-3-ol and 2-amino-4,6-dimethylpyrimidin-5-ol Derivatives as Selective Fibroblast Growth Factor Receptor 4 Inhibitors: Design, Synthesis, Molecular Docking, and Anti-hepatocellular Carcinoma Efficacy Evaluation. Taylor & Francis Group, 2022.